Breast Cancer New Protocol: Neoadj Pembrolizumab + TP for her2+ Breast Cancer Ulas D. Bayraktar, MD 2025-05-05
GastroEsophageal Cancer New Protocol: Atezolizumab and Trastuzumab with CapeOx for Periop Her2+ Gastric Cancer Ulas D. Bayraktar, MD 2025-05-04
Breast Cancer New Protocol: Eribulin with Trastuzumab-Pertuzumab in First-Line Breast Cancer Ulas D. Bayraktar, MD 2025-04-22
Biliary Tract Cancer New Indication: Trastuzumab plus CISplatin-Gemcitabine in Biliary Tract Cancers Ulas D. Bayraktar, MD 2023-11-20
